Glossary:TAG-00135-Inv-ntr

Glossary > Trial site

Trial site
Tag-ID	TAG-00135-Inv-ntr
English	Investigator site / Clinical site / Trial site
French	Centre investigateur / Site d'essai / Site clinique
German	Prüfstelle / Prüfzentrum / Studienzentrum

References

	Scope	Document part	Language	Document
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68 Paragraph 5	IVD	Article 68 Paragraph 5	EN	EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 15	HM	Article 15	EN	EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50	HM	Article 50	EN	EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix I	HM	Appendix I	EN	GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 3 Part 1 1.	HM	Schedule 3 Part 1 1.	EN	GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.3	MD	10.3	EN	ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4	HM	1.4	EN	WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.7	HM	4.7	EN	WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 6.2	HM	6.2	EN	WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995